MicroRNA-21 abrogates palmitate-induced cardiomyocyte apoptosis through caspase-3/NF-κB signal pathways.

OBJECTIVE: The aim of the study was to investigate the role of microRNA-21 (miR-21) in cardiomyocyte apoptosis and to determine a possible mechanism.
METHODS: H9c2 embryonic rat heart-derived cells were used in the study. Cell viability was determined using the 3-(4.5-dimethyl-2-thiazolyl)-2,5- diphenyl-2-H-tetrazolium bromide (MTT) assay, and flow cytometry was used to evaluate cell apoptosis. Reverse transcription-polymerase chain reaction and western blot assays were used to detect mRNA and protein expression of the apoptosis-related proteins and miR-21. ELISA was used to detect reactive oxygen species (ROS).
RESULTS: Palmitate exposure greatly reduced miR-21 expression in cardiomyocytes. Apoptosis increased when miR-21 was inhibited with or without palmitate exposure. Consistently, reduced apoptosis was observed when miR-21 was overexpressed in cardiomyocytes. Caspase-3 activity was reduced after palmitate exposure. Bcl-2 protein expression was increased in H9c2 cells when transfected with the miR-21 mimic. MiR-21 overexpression alone did not induce ROS or DNA fragmentation; however, in conjunction with palmitate exposure, miR-21 mimic reduced ROS and DNA fragmentation. Moreover, palmitate administration overcame the antioxidant effect of 3 mM N-acetylcysteine to significantly inhibit apoptosis, DNA fragmentation, and caspase-3 activity. The exposure to palmitate greatly reduced p65 and p-p38 expression in the nucleus. A p38 inhibitor had no effect on the expression of Bcl-2 and cleaved caspase-3 in H9c2 cells alone; however, when combined with exposure to palmitate the p38 inhibitor induced Bcl-2 expression and inhibited caspase-3 activity. The p38 inhibitor by itself did not induce apoptosis, ROS production, or DNA fragmentation in H9c2 cells, but when palmitate was included with the p38 inhibitor, apoptosis, ROS production, and DNA fragmentation were reduced.
CONCLUSION: miR-21 protects cardiomyocytes from apoptosis that is induced by palmitate through the caspase-3/NF-κB signal pathways.

Introduction

Mature cardiomyocytes are easily influenced by fatty acid metabolism disorders caused by diseases such as diabetes, obesity, and hyperlipidemia (1). An abnormal accumulation of lipid in the myocardium results in glucose and lipid metabolism disorders, which damage heart function (2, 3). Saturated fatty acids are especially damaging and have been reported to cause apoptosis of cardiomyocytes, islet beta cells, hepatic cells, vascular smooth muscle cells, and vascular endothelial cells (4-7). Of the saturated fatty acids, palmitate has been shown to accumulate in cardiomyocytes, leading to so-called “fat toxicity,” which can result in heart dysfunction, heart failure, and apoptosis (8-12). MicroRNAs (miRs), a class of endogenous non-coding RNAs approximately 22 nucleotides long, negatively regulate gene expression by inhibiting mRNA transcription. They play an important role in cell proliferation, metabolism, differentiation, and the occurrence and development of various diseases (13-15). The changes in the levels of miRs are related to many cardiac diseases, including arrhythmia, myocardial infarction, myocardial fibrosis, and heart failure (16-19). A previous study detected abnormal expression of miR-21 in H9c2 cells when they were exposed to palmitate. The miR-21 expression level directly correlated with the apoptosis rate, indicating that miR-21 might be involved in the regulation of cell death. Palmitate was reported to induce apoptosis of cardiomyocytes through either the PI3K/AKT or AMPK signaling pathway (20, 21). In models of bacterial lipopolysaccharide induction, a reactive oxygen species (ROS)-dependent pathway was found to be regulated by miR-146a (22). Furthermore, the expression of 23 miRNAs was altered after H2O2 treatment in normal human fibroblasts (23). All these observations indicate that the expression of miRs play a significant role in fatty acid-induced apoptosis. However, few studies have focused on the exact mechanism of how certain miRs work. In the present study, we employ a model of palmitate-induced cardiomyocyte apoptosis to explore whether miR-21 is related to the regulation of cell death and to investigate a possible underlying mechanism.

Methods

Cell culture

H9c2 embryonic rat heart-derived cells were obtained from Academia Sinica (Shanghai, China). Cells were cultured in DMEM containing 15% FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin at 37°C in a humidified atmosphere of 5% CO2.

Cell viability assay

H9c2 cells were seeded at a density of 5×103 cells/well in 96-well plates, and cell viability was determined using the MTT assay. The cells were incubated with palmitate at various concentrations (0.2, 0.4, and 0.6 mM) for 12, 18, and 24 h. Following palmitate incubation, each well was washed twice with PBS to remove the medium before 10 µL 0.5 mg/mL MTT was added to each well and incubated for an additional 4 h at 37°C. The absorbance at 490 nm was read on a microplate reader and used as a measurement of cell viability. The absorbance was normalized to cells incubated in control medium, which were considered 100% viable.

Flow cytometry

Apoptotic cells were detected using the Annexin V-FITC/propidium iodide kit (Vazyme Biotech, Nanjing, China) according to the manufacturer’s instructions. In brief, the palmitate-treated cells were washed twice with PBS and dislodged using 0.25% trypsin. Cells were centrifuged and resuspended in PBS containing 50 µg/mL propidium iodide, 0.1 g/L RNase, and 1% bovine serum albumin. The cells were then incubated at 37°C for 30 min in the dark before analysis.

Western blot analysis

Cell lysates were prepared and 20 µg of these were separated by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Specific monoclonal anti-cleaved caspase-3 [Cell Signal Technology (CST), SN: 4380, dilution: 1:2000], monoclonal anti-Bcl-2 (CST, SN: 11988, dilution: 1:2000), monoclonal anti-p65 (CST, SN: 5741, dilution: 1:2000), monoclonal anti-p-p38 (CST, SN: 3195, dilution: 1:2000), and monoclonal anti-β-actin (CST, SN: 8457, dilution: 1:4000) antibodies were used. HRP-conjugated immunoglobulin was used as the secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). West Pico chemiluminescence was used as the substrate to visualize protein bands, which were quantified using densitometric image analysis software (Image Master VDS; Pharmacia Biotech) and normalized to β-actin expression.

Reverse transcription-polymerase chain reaction (RT-PCR)

Total RNA was isolated using the Trizol reagent (Invitrogen, San Diego, CA, USA). The first strand of cDNA was synthesized using a reverse transcription kit (PrimeScript™ Synthesis kit, Takara Bio, Inc., Dalian, China). RT-PCR was performed using the SYBR Premix Ex Taq Kit (Takara Bio, Inc., Dalian, China) on an Applied Biosystems 7500 Real-Time PCR system (Applied Biosystems, White Plains, NY, USA). β-actin was used as an internal control. The experiment was performed in triplicates. Primers for miR-21 were designed and synthesized by Invitrogen China.

ROS detection

ROS production was measured using an ELISA kit (Vazyme Biotech) according to the manufacturer’s instructions. Measurements are given as fold changes compared with control.

Statistical analysis

Experimental results are presented as the mean ± standard deviation. Comparisons between two groups were conducted using the two-tailed Student’s t-test or the Chi square test (SPSS 18.0, Chicago, IL, USA). The comparison of multiple groups was analyzed using ANOVA with Holm–Sidak’s or Dunnett’s multiple comparisons test (GraphPad Prism 6.0, La Jolla, CA, USA). Differences were considered statistically significant when the p value was <0.05.

Results

Palmitate inhibits H9c2 proliferation and induces H9c2 apoptosis

H9c2 was exposed to 0.2, 0.4, 0.6, and 0.8 mM palmitate for 12, 18, and 24 h. Significant differences in cell viability were detected at 0.4 and 0.6 mM palmitate exposure for 18 and 24 h when compared with controls, which had not been treated with palmitate (Fig. 1a, Fig. 1 Table 1-3). The apoptosis rate of H9c2 cells was measured after 24 h of exposure to 0.4 and 0.6 mM palmitate. The rate significantly increased in response to both concentrations compared with control, but there was no significant difference in the apoptosis rate between the two concentrations (Fig. 1b, Fig. 1 Table 1-3). Based on this, 0.4 mM palmitate for 24 h was used as the exposure condition in subsequent experiments. In addition, both the expression of cleaved caspase-3 and caspase-3 activity (3-fold) was increased, whereas Bcl-2 expression was inhibited, compared with the β-actin internal control after 24 h of exposure to palmitate (Fig. 1c and 1d, Table 1-3).

Figure 1

Palmitate-induced H9c2 cardiomyocyte apoptosis.

(a) H9c2 cells treated with palmitate. (b) The apoptosis rate of H9c2 significantly increased after 24 h of exposure to 0.4 and 0.6 mM palmitate compared with the control. No significant difference in apoptosis was observed between the two concentrations. Western blot detected cleaved caspase-3 (c) and Bcl-2 (d) expression after 24 h of exposure to 0.4 mM palmitate

Table 3

Relative caspase-3 activity of H9c2 cells after 24 h of exposure to 0.4 mM palmitate

	CTRL	0.4 mM
Mean±SEM	1.000±0.007	2.416±0.169
n=5

SEM - standard error of the mean

Table 1

Relative cell viabilities of H9c2 treated with different concentrations of palmitate (0, 0.2, 0.4, 0.6, and 0.8 mM) for varying periods of time (12, 18, and 24 h)

	12h			18h			24h
	Mean	SD	n	Mean	SD	n	Mean	SD	n
0	1	0.03	5	1	0.04	5	1	0.02	5
0.2	0.93	0.18	5	0.81	0.21	5	0.83	0.19	5
0.4	0.81	0.21	5	0.71	0,11	5	0.59	0.12	5
0.6	0.69	0.22	5	0.58	0.20	5	0.49	0.15	5
0.8	0.55	0.18	5	0.51	0.27	5	0.46	0.23	5

SD - standard deviation

Role of miR-21 in palmitate-induced H9c2 cell apoptosis

Compared with an internal control, miR-21 expression was reduced almost 3-fold after 24 h of exposure to 0.4 mM palmitate (Fig. 2a, Fig. 2 Table 4-6). The apoptosis rate was increased when miR-21 was inhibited by an antagomir (an inhibitory miR-21 mimic), both in the presence and absence of palmitate, whereas a reduction in apoptosis was observed when a miR-21 mimic was expressed by transfection (Fig. 2b, Fig. 2 Table 4-6). Moreover, cleaved caspase-3 expression was stable when transfected with the miR-21 mimic and was reduced after palmitate treatment (Fig. 2c, Fig. 2 Table 4-6).

Figure 2

Role of miR-21 in palmitate-induced H9c2 cell apoptosis.

(a) MiR-21 expression was reduced by 60% after 24 h of exposure to 0.4 mM palmitate. (b) H9c2 cell apoptosis rate was detected with transfection of a miR-21 antagomir (a miR-21 mimic) and a scrambled oligonucleotide after 24 h of exposure to 0.4 mM palmitate. (c) Caspase-3 expression was measured with transfection of the miR-21 mimic with or without palmitate exposure

Table 6

Relative caspase-3 activity of H9c2 cells transfected with a miR-21 mimic and a scrambled oligonucleotide after 24 h exposure to 0.4 mM palmitate (mean±SD, n=5)

	Scrambled oligo	miR-21 mimic
CTRL	1.00±0.34	0.92±0.28
PAL	2.44±0.52	1.33±0.41

Table 4

Relative miR-21 expression of H9c2 cells after 24 h of exposure to 0.4 mM palmitate

	CTRL	PAL
Mean±SEM	1.000±0.066	0.410±0.139
n=5

SEM - standard error of the mean

Effect of miR-21 on Bcl-2 expression and ROS production

Bcl-2 protein expression was higher in H9c2 cells that were transfected with the miR-21 mimic in combination with palmitate exposure (Fig. 3a, Fig. 3 Table 7-12). The overexpressed miR 21 alone did not induce ROS and DNA fragmentation in H9c2 cells. However, when cells were treated with palmitate, the miR-21 mimic downregulated ROS and DNA fragmentation compared with a scrambled oligo group (Fig. 3b and 3c, Table 7-12). Moreover, 3 mM N acetylcysteine (NAC, an antioxidant agent) significantly inhibited apoptosis, DNA fragmentation, and cleaved caspase-3 expression in H9c2 cells exposed to palmitate (Fig. 3d, 3e, and 3f, Table 7-12).

Figure 3

Effect of miR-21 on Bcl-2 expression and ROS production.

The expression of Bcl-2 (a), ROS (b), and DNA fragmentation (c) production were affected by the overexpression of miR-21 in H9c2 cells treated with palmitate. The effect of N acetylcysteine on apoptosis of H9c2 cells induced by palmitate (d, e, and f)

Table 12

Effect of N-acetylcysteine on relative caspase-3 activity of H9c2 cells after 24 h exposure to 0.4 mM palmitate (mean±SD, n=5)

	Vehicle	NAC (3 mM)
CTRL	1.00±0.13	0.90±0.25
PAL	2.02±0.37	1.31±0.49

Table 7

Relative Bcl-2 expression of H9c2 cells transfected with a miR-21 mimic after 24 h exposure to 0.4 mM palmitate

	PAL	PAL+miR-21 mimic
Mean±SEM	1.000±0.0492	1.621±0.2737
n=5

MiR-21 affects nuclear factor κB pathway on palmitate-induced H9c2 cell apoptosis

After 24 h of exposure to palmitate, the expression of p65, a key proinflammatory component of the nuclear factor κB (NF-κB) pathway in the nucleus, was significantly increased (Fig. 4a, Fig. 4 Table 13-19). The overexpression of miR-21 did not affect the expression levels of p65 either in the nucleus or in the cytoplasm but did completely suppress the increase of nuclear p65 expression after exposure to palmitate (Fig. 4a, Fig. 4 Table 13-19). No significant change in phosphorylated mitogen-activated protein kinase (MAPK) p38 (p-p38), a marker of inflammation and apoptosis, was observed in H9c2 cells transfected with the miR-21 mimic (Fig. 4b, Fig. 4 Table 13-19). However, miR-21 suppressed the upregulation of p-p38 expression after exposure to palmitate (Fig. 4b, Fig. 4 Table 13-19). Without palmitate stimulus, a p38 inhibitor had no effect on the expression of Bcl-2 or cleaved caspase-3 in H9c2 cells. When palmitate was included, the p38 inhibitor induced Bcl-2 expression and inhibited caspase-3 activity (Fig. 4c, Fig. 4 Table 13-19). The p38 inhibitor did not induce apoptosis, ROS production, or DNA fragmentation in H9c2 cells; however, in the presence of palmitate, the p38 inhibitor reduced apoptosis, ROS production, and DNA fragmentation (Fig. 4d-4f, Table 13-19).

Figure 4

miR-21 is involved in NF-κB pathway-related apoptosis and DNA fragmentation.

miR-21 affects p65 expression (a) and phosphorylation of p38 (b) in H9c2 cells treated with palmitate. An inhibitor of p38 rescues palmitate-induced H9c2 cell apoptosis (c, d, e, and f)

Table 19

Effect of p38 MAPK inhibitor on relative DNA fragmentation in H9c2 cells after 24 h exposure to 0.4 mM palmitate (mean±SEM, n=5)

	Vehicle	p38 MAPK inhibitor
CTRL	1.000±0.103	0.964±0.147
PAL	1.997±0.277	1.261±0.196

Table 13

Relative p65 expression (nucleus and cytosol) of H9c2 cells transfected with a miR-21 mimic after 24 h exposure to 0.4 mM palmitate (mean±SEM, n=5)

	CTRL	miR-21 mimic	PAL	PAL+miR-21 mimic
Nucleus	0.335±0.019	0.346±0.017	0.568±0.018	0.434±0.020
Cytosol	0.483±0.019	0.503±0.016	0.610±0.028	0.603±0.022

Discussion

It is well known that the loss of cardiomyocytes is a major factor that contributes to cardiac dysfunction and heart failure (24). Inhibition of cardiomyocyte apoptosis is a potential strategy to prevent the development of heart failure (25). In many heart diseases, saturated fatty acids were found to play a key role in myocardial injury, a consequence of cardiomyocyte apoptosis (26-28). Large amounts of palmitate, a key saturated fatty acid, can accumulate in cardiomyocytes and induce apoptosis (29); however, the exact pathway of palmitate-induced apoptosis is yet to be determined. MiRs are involved in the regulation of gene transcription. They can specifically recognize and target the 3′ non-coding region of mRNA at the transcriptional level, causing degradation or inhibition of mRNA translation, thereby regulating gene expression. An altered gene regulation plays an important role in the occurrence and development of various diseases (30). In the heart, miRs have been found to regulate various pathophysiological processes, including cardiac remodeling, cardiac development, myocardial fibrosis, angiogenesis, and cardiomyocyte apoptosis (31). In terminally differentiated cells, such as cardiomyocytes, regulation of apoptosis is crucial because inadequate or excessive apoptosis can lead to atherosclerosis, myocardial infarction, heart failure, and other cardiovascular diseases (32).

It has been found in recent years that miR-21 is highly expressed in vascular smooth muscle cells, vascular endothelial cells, cardiomyocytes, and cardiac fibroblasts. The levels of miR-21 expression have been shown to be altered in various cardiovascular diseases, indicating that miR-21 is involved in the occurrence and development of cardiovascular diseases (33-36). Studies have confirmed that miR-21 is an apoptosis-related miR, which regulates cell cycle (37, 38). Sayed et al. established a model of cardiomyocyte apoptosis by continuous hypoxia and observed the downregulation of miR-21 and upregulation of FasL, which was reversed by AKT activation. However, the overexpression of miR-21 inhibited upregulation of PTEN and FasL and increased the levels of phosphorylated AKT, leading to reduced infarct size and alleviation of heart failure (39). In the work presented here, we induced apoptosis in H9c2 cells by addition of 0.4 and 0.6 mM palmitate. The apoptosis rate was significantly higher than that in the non induced control group. Moreover, palmitate increased the expression of cleaved caspase-3 and decreased the expression of Bcl-2, indicating that the caspase and Bcl-2/Bax pathways might be involved. Bcl-2 and caspase-3 are two classic markers of apoptosis. The Bcl-2 family of genes affects mitochondrial transmembrane potential and has been extensively studied. The antiapoptotic gene Bcl-2 and the proapoptotic gene Bax are two representative members of the Bcl-2 family. Bcl-2 was the first gene found to inhibit apoptosis (40). High expression of Bcl 2 helps maintain stability of the mitochondrial membrane potential by keeping the mitochondrial permeability transition pore in a closed state, preventing the release of mitochondrial apoptotic proteins, and subsequently cell apoptosis. The caspase family of genes plays an essential role in mediating cell apoptosis, among which caspase-3 is the main executor of cell apoptosis and can be activated by various upstream factors (41-44). Activated caspase-3 induces the activation of other caspase members in a protease cascade, which ultimately leads to apoptosis (45). Studies have shown that miR-21 overexpression could inhibit H2O2-induced apoptosis of cardiomyocytes by downregulating the expression of PDCD4 (46), a protective effect also observed in hypoxia/reoxygenation-induced cell apoptosis and in rat hearts after ischemia/reperfusion injury in vivo (37). In the present study, we found that the overexpression of a miR-21 mimic could inhibit the apoptosis induced by palmitate, whereas the low expression of miR-21 accelerated the process. ROS production and DNA fragmentation, which correlate with the apoptosis, were detected in the cells. The downregulation of miR-21 in cardiomyocyte apoptosis has been reported by other groups and has been shown to correlate with increased expression of FasL protein. It was also found that the expression of miR-21 in cardiac fibroblasts was significantly higher than that in normal cardiomyocytes. In the stress state, the expression of miR-21 in cardiac fibroblasts can significantly activate extracellular signal regulated kinase (ERK)/MAPK pathway proteins and promote the proliferation of fibroblasts and fibrosis (47).

Our work has demonstrated a new pathway by which miR-21 regulates apoptosis in cardiomyocytes, namely through the caspase-3/NF-κB pathway. NF-κB is an inducible transcription factor responsible for the expression of various genes involved in inflammation, injury, apoptosis, embryonic development, and proliferation (48, 49). As the main functional element, p65 is involved in the regulation of various physiological and pathophysiological events (50-52). We showed that p65 expression level in the nucleus increased by the exposure to palmitate, which was inhibited by miR-21. The overexpression of miR-21 did not affect the expression levels of p65 either in the nucleus or in the cytoplasm but did completely suppress the increase of nuclear p65 expression after exposure to palmitate. A combination of palmitate and a p38 inhibitor induced Bcl-2 expression and reduced caspase-3 activity. In addition, the p38 inhibitor reduced palmitate-induced apoptosis, suggesting that p38 is a key factor in cardiomyocyte apoptosis. Additionally, p38 is one of the first identified transcription factors, which is regulated by phosphorylation; p38 is involved in various pathophysiological processes, including cell growth, proliferation, differentiation, and apoptosis, by regulating the expression of many downstream target genes. Phospho-p38 causes cardiomyocyte damage by promoting inflammation and cell apoptosis. Studies have shown that p38 can be activated by various inflammatory factors, including oxygen free radicals released after myocardial ischemia/reperfusion injury and calcium overload. p38 activation induces expression of some early genes, such as c-fos, c-jun, and NF-κB (53, 54), which upregulates the expression of cytokines, such as TNF-α, IL-1, and IL-8, leading to secondary myocardial damage (55-57). We also observed alterations of ROS and the amount of DNA fragmentation in H9c2 cells. ROS can activate several pro-apoptotic signaling pathways, such as MAPK p38, c-Jun N-terminal kinase, apoptosis signal regulating kinase 1, and ERK (58).

Study limitations

For this study, we used the embryonic rat heart-derived cell-line H9c2. The link between apoptosis and the miR-21/caspase-3/NF-κB pathways makes these pathways promising as therapeutic targets for heart disease; however, the findings need further study and validation in in vivo experiments and human cells to confirm the potential therapeutic benefit.

Conclusion

In summary, miR-21 protects cardiomyocytes from apoptosis induced by palmitate through the caspase-3/NF-κB pathway.

Table 2

Apoptosis rate of H9c2 after 24 h of exposure to 0, 0.4, and 0.6 mM palmitate

	0 mM	0.4 mM	0.6 mM
Mean±SD	6.220±0.2587	25.80±2.103	27.97±2.692
n=3

SD - standard deviation

Table 5

Apoptosis rate of H9c2 cells transfected with a miR-21 antagomir (or a miR 21 mimic) and a scrambled oligonucleotide after 24 h exposure to 0.4 mM palmitate (mean±SD, n=5)

	Scrambled oligo	Antagomir	miR-21 mimic
CTRL	5.88±0.40	25.67±0.22	4.53±0.55
PAL	24.22±0.13	37.92±0.37	12.81±0.32

Table 8

Relative ROS production of H9c2 cells transfected with a miR-21 mimic and a scrambled oligonucleotide after 24 h exposure to 0.4 mM palmitate (mean±SD, n=5)

	Scrambled oligo	miR-21 mimic
CTRL	1.00±0.12	0.89±0.24
PAL	1.48±0.32	1.18±0.46

Table 9

Relative DNA fragmentation of H9c2 cells transfected with a miR-21 mimic and a scrambled oligonucleotide after 24 h exposure to 0.4 mM palmitate (mean±SD, n=5)

	Scrambled oligo	miR-21 mimic
CTRL	1.00±0.21	0.92±0.32
PAL	2.09±0.36	1.31±0.44

Table 10

Effect of N-acetylcysteine on apoptosis of H9c2 cells induced by palmitate (mean±SD, n=5)

	Vehicle	NAC (3 mM)
CTRL	5.03±0.45	4.43±0.65
PAL	25.73±1.81	11.80±0.51

Table 11

Effect of N-acetylcysteine on DNA fragmentation of H9c2 cells after 24 h exposure to 0.4 mM palmitate (mean±SD, n=5)

	Vehicle	NAC (3 mM)
CTRL	1.00±0.18	0.88±0.31
PAL	2.09±0.31	1.21±0.23

Table 14

Relative phospho-p38 expression of H9c2 cells transfected with a miR-21 mimic after 24 h exposure to 0.4 mM palmitate

	CTRL	miR-21 mimic	PAL	PAL+miR-21 mimic
Mean±SEM	1.000±0.148	0.940±0.201	3.474±0.344	1.841±0.233
n=5

SEM - standard error of the mean

Table 15

Effect of p38 MAPK inhibitor on relative Bcl-2 and caspase-3 expression of H9c2 cells after 24 h exposure to 0.4 mM palmitate (mean±SEM, n=5)

	CTRL	p38 MAPK inhibitor	PAL	PAL+p38 MAPK inhibitor
Bcl-2	8.849±0.452	7.911±0.501	3.802±0.237	7.038±0.492
Caspase-3	0.322±0.009	0.431±0.011	0.812±0.014	0.623±0.015

Table 16

Effect of p38 MAPK inhibitor on relative caspase-3 activity in H9c2 cells after 24 h exposure to 0.4 mM palmitate (mean±SEM, n=5)

	Vehicle	p38 MAPK inhibitor
CTRL	1.000±0.0134	0.960±0.063
PAL	1.920±0.098	1.310±0.183

Table 17

Effect of p38 MAPK inhibitor on apoptosis of H9c2 cells induced by palmitate (mean±SEM, n=5)

	Vehicle	p38 MAPK inhibitor
CTRL	5.030±0.179	4.930±0.291
PAL	25.73±0.854	15.80±0.411

Table 18

Effect of p38 MAPK inhibitor on relative ROS production in H9c2 cells after 24 h exposure to 0.4 mM palmitate (mean±SEM, n=5)

	Vehicle	p38 MAPK inhibitor
CTRL	1.000±0.054	0.932±0.107
PAL	1.687±0.112	1.280±0.183